Accuray Incorporated (ARAY)
NASDAQ: ARAY · IEX Real-Time Price · USD
1.800
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.810
+0.010 (0.56%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Accuray Revenue
Accuray had revenue of $430.55M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $101.13M. In the fiscal year ending June 30, 2023, Accuray had annual revenue of $447.61M with 4.12% growth.
Revenue (ttm)
$430.55M
Revenue Growth
-2.00%
P/S Ratio
0.41
Revenue / Employee
$420,463
Employees
1,024
Market Cap
178.64M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
Jun 30, 2019 | 418.79M | 13.89M | 3.43% |
Jun 30, 2018 | 404.90M | 21.48M | 5.60% |
Jun 30, 2017 | 383.41M | -15.39M | -3.86% |
Jun 30, 2016 | 398.80M | 19.00M | 5.00% |
Jun 30, 2015 | 379.80M | 10.38M | 2.81% |
Jun 30, 2014 | 369.42M | 53.45M | 16.91% |
Jun 30, 2013 | 315.97M | -93.25M | -22.79% |
Jun 30, 2012 | 409.22M | 186.94M | 84.10% |
Jun 30, 2011 | 222.28M | 659.00K | 0.30% |
Jun 30, 2010 | 221.63M | -11.97M | -5.13% |
Jun 30, 2009 | 233.60M | 23.22M | 11.04% |
Jun 30, 2008 | 210.38M | 66.24M | 45.95% |
Jun 30, 2007 | 144.15M | 91.25M | 172.50% |
Jun 30, 2006 | 52.90M | 23.27M | 78.53% |
Jun 30, 2005 | 29.63M | 10.06M | 51.41% |
Jun 30, 2004 | 19.57M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Puma Biotechnology | 226.63M |
OptimizeRx | 78.21M |
Innate Pharma | 68.49M |
Metagenomi | 47.26M |
Fennec Pharmaceuticals | 44.95M |
MediWound | 19.85M |
ARAY News
- 25 days ago - Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care - PRNewsWire
- 4 weeks ago - Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients - PRNewsWire
- 5 weeks ago - Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration - PRNewsWire
- 2 months ago - Accuray to Participate in the Jefferies Global Healthcare Conference 2024 - PRNewsWire
- 2 months ago - Accuray Reports Fiscal 2024 Third Quarter Financial Results - PRNewsWire
- 3 months ago - Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 - PRNewsWire
- 3 months ago - Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland - PRNewsWire
- 3 months ago - Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 - PRNewsWire